Exicure Highlights Achievements, Strategic Priorities
06 Oct 2025 //
GLOBENEWSWIRE
Exicure Completes Patient Enrollment in Phase 2 Study of GPC-100
05 May 2025 //
BUSINESSWIRE
PharmaVentures advises GPCR Therapeutics on their acquisition of Burixafor
24 Nov 2020 //
PRNEWSWIRE

Market Place
Sourcing Support